ReviewCurrent neurology and neuroscience reports2023
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies.
W Daniel Chapman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewCurrent neurology and neuroscience reports2023
W Daniel Chapman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.